NanoFUSE Biologics

medical devices

About

NanoFUSE Biologics is a biotechnology company that specializes in a patented synthetic bioactive ceramic-based osteobiologic technology known as 45S5 bioglass, combined with demineralized bone matrix (DBM). It is the first and only FDA-approved product that integrates these two components into a single osteobiologic product, designed to promote new bone formation and healing in bony voids or gaps. The core product, NanoFUSE, works by releasing beneficial ions when mixed with body fluids, which stimulates cell activity and supports bone growth within 24 hours. Its advantages include anti-microbial properties, customizable formulations, and a proven clinical track record in spinal fusion and bone healing. NanoFUSE Biologics primarily serves the medical and surgical markets in the United States, focusing on applications that require effective bone regeneration and fusion.

Technologies

Typekit YouTube Mobile Friendly Remote

Keywords

medical equipment manufacturing bone graft substitute degradation in body fluids bioglass bioactive glass in tissue engineering antimicrobial properties 45s5 bioglass bioactive ceramic regenerative medicine ion release osteinductivity b2b calcium hydroxyapatite flowable putty medical devices bioactive glass for periodontal treatment synthetic bioactive ceramic bioactive glass in oral and maxillofacial surgery bioactive glass for infected bone osteoconductivity regenerative therapy biomaterial scaffolds bone tissue engineering bone regeneration fda-approved bioactive glass for large bone repair biomaterials medical equipment and supplies manufacturing bioactive glass in spinal fusion demineralized bone matrix

Location

350 Main St, Malden, Massachusetts, United States, 02148

Related Companies

Companies in the same industry